|
|
|  |
 |
 |
 |
 |
|
| |
| Stenting |
First performed in the mid-1980s, and approved by the
U.S. Food and Drug Administration (FDA) in 1994, stenting is a catheter-based
procedure in which a small, expandable wire mesh tube (stent) is inserted
into a diseased artery, serving as a scaffold to hold it open. Currently,
stenting is performed most often in conjunction with other catheter-based
procedures, such as balloon
angioplasty or rotational atherectomy.
The other procedures are used to partially reduce the narrowing caused
by atherosclerosis, and the stent typically allows for an excellent
final result to be obtained with little to no narrowing remaining
within the coronary arteries. By doing a stent insertion along with
these other procedures, the risk of the artery re-narrowing (restenosis)
is reduced, and the risk of abrupt vessel closures during or within
24 hours of the procedure is nearly eliminated.
Within one month, the stent becomes covered with a thin layer
of the artery’s inner lining cells. It will not be affected
by a metal detector or most mechanical equipment. The success of
a stenting procedure can be threatened by risk factors such as smoking
or high cholesterol levels, which unchecked could lead to new blockages
in the coronary arteries. Therefore, people receiving stents are
strongly encouraged to learn and practice healthy lifestyle behaviors
for good heart health.
Read about the new FDA-approved, Drug-Eluting Stent |
|
 |
 |
 |
 |
|
 |
|
 |